Assessing the robustness of COVID-19 vaccine efficacy trials: systematic review and meta-analysis, January 2023
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessing the robustness of COVID-19 vaccine efficacy trials: systematic review and meta-analysis, January 2023
Authors
Keywords
-
Journal
Eurosurveillance
Volume 28, Issue 22, Pages -
Publisher
European Centre for Disease Control and Prevention (ECDC)
Online
2023-06-03
DOI
10.2807/1560-7917.es.2023.28.22.2200706
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
- (2022) Lulu Bravo et al. LANCET
- Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial
- (2022) Rolando Pajon et al. NATURE MEDICINE
- Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S
- (2022) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
- (2022) Akash Khobragade et al. LANCET
- Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial
- (2022) Igor Smolenov et al. LANCET INFECTIOUS DISEASES
- Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
- (2022) Karen J. Hager et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
- (2022) Lianpan Dai et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
- (2022) Edson D. Moreira et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
- (2022) Ramy Mohamed Ghazy et al. Vaccines
- The Fragility of Statistically Significant Results in Randomized Clinical Trials for COVID-19
- (2022) Takahiro Itaya et al. JAMA Network Open
- Thresholds for interpreting the fragility index derived from sample of randomised controlled trials in cardiology: a meta-epidemiologic study
- (2022) Mohammad Hassan Murad et al. BMJ Evidence-Based Medicine
- Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial
- (2022) Xuan-Yi Wang et al. Emerging Microbes & Infections
- An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
- (2022) Natalie Gabrielle Marchevsky et al. EBioMedicine
- Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial
- (2022) Paul T Heath et al. CLINICAL INFECTIOUS DISEASES
- Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial
- (2022) Payam Tabarsi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial
- (2022) Karin Hardt et al. LANCET INFECTIOUS DISEASES
- Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial
- (2022) Mine Durusu Tanriover et al. Vaccines
- Meta-analyses in paediatric surgery are often fragile: implications and consequences
- (2021) Arne Schröder et al. PEDIATRIC SURGERY INTERNATIONAL
- The Statistical Fragility of Platelet-Rich Plasma in Rotator Cuff Surgery: A Systematic Review and Meta-analysis
- (2021) Robert L. Parisien et al. AMERICAN JOURNAL OF SPORTS MEDICINE
- The Fragility Index of Hip Arthroscopy Randomized Controlled Trials: A Systematic Survey
- (2021) David R. Maldonado et al. ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis
- (2021) X. Huang et al. OSTEOPOROSIS INTERNATIONAL
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
- (2021) Nina H. Schultz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- The Fragility of Statistical Significance in Cartilage Restoration of the Knee: A Systematic Review of Randomized Controlled Trials
- (2021) Robert L. Parisien et al. Cartilage
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
- (2021) Nawal Al Kaabi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
- (2021) Mine Durusu Tanriover et al. LANCET
- Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
- (2021) Robert W. Frenck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
- (2021) Hana M. El Sahly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18–59 Years: An Interim Analysis in Indonesia
- (2021) Eddy Fadlyana et al. VACCINE
- Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
- (2021) Scott A Halperin et al. LANCET
- Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
- (2021) Raches Ella et al. LANCET
- Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
- (2021) Ann R. Falsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
- (2021) Lisa M. Dunkle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
- (2021) Emmanuel B. Walter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fragility indices for only sufficiently likely modifications
- (2021) Benjamin R. Baer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
- (2021) Sue Ann Costa Clemens et al. Nature Communications
- Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis
- (2021) Victoria Rotshild et al. Scientific Reports
- Fragility Index and Fragility Quotient in Randomized Controlled Trials on Corticosteroids in ARDS Due to COVID-19 and Non-COVID-19 Etiology
- (2021) Maria Vargas et al. Journal of Clinical Medicine
- Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
- (2021) Peter G Kremsner et al. LANCET INFECTIOUS DISEASES
- Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial
- (2021) Stephen J. Thomas et al. VACCINE
- Evaluation of the fragility of pivotal trials used to support US Food and Drug Administration approval for plaque psoriasis
- (2020) Sophia Z. Shalhout et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Factors that impact fragility index and their visualizations
- (2020) Lifeng Lin JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Application of the Reverse Fragility Index to Statistically Nonsignificant Randomized Clinical Trial Results
- (2020) Muhammad Shahzeb Khan et al. JAMA Network Open
- The Fragility Index and Trial Significance
- (2020) Alexander Chaitoff et al. JAMA Internal Medicine
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Fragility Index—P Values Reimagined, Flaws and All
- (2019) Sergio A. Acuna et al. JAMA Surgery
- Over-reliance on p values in Urology: Fragility of findings in the hydronephrosis literature calls for systematic reporting of robustness indicators
- (2019) Mandy Rickard et al. UROLOGY
- The fragility index of practice changing clinical trials is low and highly correlated with P-values
- (2019) Joshua D. Niforatos et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Fragility Index in Cardiovascular Randomized Controlled Trials
- (2019) Muhammad Shahzeb Khan et al.
- The Fragility Index in Randomized Clinical Trials as a Means of Optimizing Patient Care
- (2018) Christopher J. Tignanelli et al. JAMA Surgery
- The ASA's Statement onp-Values: Context, Process, and Purpose
- (2016) Ronald L. Wasserstein et al. AMERICAN STATISTICIAN
- Does Sample Size Matter When Interpreting the Fragility Index?
- (2016) Wael Ahmed et al. CRITICAL CARE MEDICINE
- Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations
- (2016) Sander Greenland et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index
- (2014) Michael Walsh et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Statistics in Brief: The Importance of Sample Size in the Planning and Interpretation of Medical Research
- (2008) David Jean Biau et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started